Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-28. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine in major jurisdictions | Sold as a research chemical; legal status varies |
| Anti-doping status | Prohibited by the World Anti-Doping Agency | Listed under non-approved substances or related category |
| Typical analytical method | LC-MS/MS | Used for detection and confirmation in biological samples |
| Storage temperature | −20 °C or lower for solid | Desiccated and protected from light |
| Common solution solvents | DMSO; ethanol | Aqueous solubility is limited |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
The empire's inhabitants, today generally known as Byzantines, regarded themselves as Romans (in Greek, Ῥωμαῖοι or Romaioi). Similarly, their Islamic contemporaries called their empire the "land of the Romans" (Bilād al-Rūm). After 800 AD, Western Europe called them "Greeks" (Graeci), as the Papacy and medieval German emperors regarded themselves as the true inheritors of Roman identity. The adjective "Byzantine", derived from Byzantion (Byzantium in Latin), the name of the Greek settlement Constantinople was established on, was only used to describe the inhabitants of the city; it did not refer to the empire, called Rhomanía (Ῥωμανία or "Romanland") by its citizens. Following the empire's fall, early modern scholars referred to it by many names, including the "Eastern Empire", the "Low Empire", the "Late Empire", the "Empire of the Greeks", "Empire of Constantinople", and "Roman Empire". The increasing use of "Byzantine" and "Byzantine Empire" may have started with Theodore Metochites or Laonikos Chalkokondyles whose work was widely propagated by Hieronymus Wolf. "Byzantine" was used adjectivally alongside terms such as "Empire of the Greeks" until the 19th century. It is now the primary term, used to refer to all aspects of the empire; some modern historians believe it should not be used because it was originally a prejudicial and inaccurate term.
Stanton became renowned around the AFL for his endurance and quickly established himself as one of the club's key players and most dangerous midfielders. He finished off an impressive season by finishing sixth in the 2007 Crichton Medal with 197 votes. In the 2008 pre-season, Stanton would be handed the number five guernsey, worn by retired club captain James Hird. Stanton struggled early in the season due to close checking from opposition players. Although he only averaged 22 possessions and kicked 18 goals in the season, his much-criticised tackling had improved vastly. Stanton finished third in the 2008 Crichton Medal, behind Matthew Lloyd and David Hille, with 188 votes. In 2009, Stanton was a significant player in an Essendon team which went through the home and away season with 10 wins, 11 defeats and a draw. He played every game in the home and away season in which they qualified in eighth position for the finals series, losing the First Elimination Final to Adelaide by 96 points. Stanton polled a career high eight votes in the Brownlow Medal and finished third in the 2009 Crichton Medal behind, Dustin Fletcher and Jobe Watson with 284 votes. Stanton played his 100th AFL game in round 2 against Fremantle.
== Overdose == In the event of an overdose of oral ketoconazole, treatment should be supportive and based on symptoms. Activated charcoal may be administered within the first hour following overdose of oral ketoconazole.
Sources: en.wikipedia.org
Volume can be determined by measuring the weight of the sample container, knowing the mass of the empty container. Sperm count and morphology can be calculated by microscopy. Sperm count can also be estimated by kits that measure the amount of a sperm-associated protein, and are suitable for home use. Computer assisted semen analysis (CASA) is a catch-all phrase for automatic or semi-automatic semen analysis techniques. Most systems are based on image analysis, but alternative methods exist such as tracking cell movement on a digitizing tablet. Computer-assisted techniques are most-often used for the assessment of sperm concentration and mobility characteristics, such as velocity and linear velocity. Nowadays, there are CASA systems, based on image analysis and using new techniques, with near perfect results, and doing full analysis in a few seconds. With some techniques, sperm concentration and motility measurements are at least as reliable as current manual methods. Raman spectroscopy has made progress in its ability to perform characterization, identification and localization of sperm nuclear DNA damage. Semen Fructose Test has made progress in its ability to perform characterization, identification and localization of sperm nuclear DNA damage.
== Inorganic analysis == In 1983 a paper was published describing the use of fast atom bombardment mass spectrometry (FAB-MS) to analyze isotopes of calcium. Glycerol was not used; samples in aqueous solution were deposited on the sample target and dried prior to analysis. The technique was effectively secondary ion mass spectrometry using a neutral primary beam. This was a welcomed development for biomedical researchers studying the nutrition and metabolism of essential minerals but lacking access to inorganic mass spectrometry instrumentation such as thermal ionization mass spectrometry or inductively-coupled plasma mass spectrometry (ICP-MS). In contrast, FAB mass spectrometers were widely found in biomedical research institutions. Multiple laboratories adopted this technique, using FAB-MS to measure isotope ratios in isotope tracer studies of calcium, iron, magnesium and zinc. The analysis of metals required minimal modification of the mass spectrometers, e.g.replacing the stainless steel sample targets with pure silver ones to eliminate background from ionization of stainless steel components. Signal acquisition systems were sometimes modified to perform peak jumping instead of scanning and to do ion counting detection. While satisfactory precision and accuracy were attained with FAB-MS, the technique was labor-intensive with a very low sample through-put rate due in part to the absence of auto-sampling options.
=== Structure-activity relationship === Hydrocortisone, or 17-hydroxycorticosterone, is under the class of glucocorticoids, which are steroids synthesized in the adrenal cortex of the kidneys. In order to illustrate its glucocorticoid activity, the A ring of hydrocortisone has a keto group in the 3rd carbon and a double bond between the 4th and 5th carbon. For the C ring of the compound, the 11th carbon has a beta hydroxyl substitution, which is also necessary for the drug to demonstrate glucocorticoid effects.
Sources: en.wikipedia.org
Under the command of Bolívar and Sucre, the experienced veterans of the combined army, mainly Colombians, destroyed a royalist army under La Serna's command in the Battle of Ayacucho on 9 December 1824. La Serna's army was numerically superior but consisted of mostly new recruits. The only significant royalist area remaining on the continent was the highland country of Upper Peru. Following the Battle of Ayacucho, the royalist troops of Upper Peru under the command of Olañeta surrendered after he died in Tumusla on 2 April 1825. Bolívar tended to favor maintaining the unity of Upper Peru with Peru, but the Upper Peruvian leaders—many former royalists, like Casimiro Olañeta, nephew of General Olañeta—gathered in a congress under Sucre's auspices supported the country's independence. Bolívar left the decision to Sucre, who went along with the congress. Sucre proclaimed Upper Peru's independence in the city which now bears his name on 6 August, bringing the main wars of independence to an end. As it became clear that there was to be no reversal of Spanish American independence, several of the new states began to receive international recognition. Early, in 1822, the United States recognized Chile, the United Provinces of the Río de la Plata, Peru, Gran Colombia, and Mexico. Britain waited until 1825, after the Battle of Ayacucho, to recognize Mexico, Gran Colombia, and Río de la Plata. Both nations recognized more Spanish American states in the next few years.
Rubidium can form Rb6O and Rb9O2 (copper-coloured) upon oxidation in air, while caesium forms an immense variety of oxides, such as the ozonide CsO3 and several brightly coloured suboxides, such as Cs7O (bronze), Cs4O (red-violet), Cs11O3 (violet), Cs3O (dark green), CsO, Cs3O2, as well as Cs7O2. The last of these may be heated under vacuum to generate Cs2O. The alkali metals can also react analogously with the heavier chalcogens (sulfur, selenium, tellurium, and polonium), and all the alkali metal chalcogenides are known (with the exception of francium's). Reaction with an excess of the chalcogen can similarly result in lower chalcogenides, with chalcogen ions containing chains of the chalcogen atoms in question. For example, sodium can react with sulfur to form the sulfide (Na2S) and various polysulfides with the formula Na2Sx (x from 2 to 6), containing the S2−x ions. Due to the basicity of the Se2− and Te2− ions, the alkali metal selenides and tellurides are alkaline in solution; when reacted directly with selenium and tellurium, alkali metal polyselenides and polytellurides are formed along with the selenides and tellurides with the Se2−x and Te2−x ions. They may be obtained directly from the elements in liquid ammonia or when air is not present, and are colourless, water-soluble compounds that air oxidises quickly back to selenium or tellurium. The alkali metal polonides are all ionic compounds containing the Po2− ion; they are very chemically stable and can be produced by direct reaction of the elements at around 300–400 °C.
=== Diaphragm check valve === A diaphragm check valve uses a flexing rubber diaphragm positioned to create a normally-closed valve. Pressure on the upstream side must be greater than the pressure on the downstream side by a certain amount, known as the pressure differential, for the check valve to open allowing flow. Once positive pressure stops, the diaphragm automatically flexes back to its original closed position. This type is used in respirators (face masks) with an exhalation valve.
== Regulatory pathways via fuzzy regions == Fuzzy regions modulate the conformational equilibrium or flexibility of the binding interface via transient interactions. Dynamic regions can also compete with binding sites or tether them to the target. Modifications of fuzzy regions by further interactions, or posttranslational modifications impact binding affinity or specificity. Alternative splicing can modulate the length of fuzzy regions resulting in context-dependent binding (e.g. tissue-specificity) on the complex. EGF/MAPK, TGF-β and WNT/Wingless signaling pathways employ tissue-specific fuzzy regions.
Sources: en.wikipedia.org
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.
Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.
Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.